As of 2024-12-12, the EV/EBITDA ratio of Aelis Farma SA (AELIS.PA) is -0.38. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AELIS.PA's latest enterprise value is 2.83 mil EUR. AELIS.PA's TTM EBITDA according to its financial statements is -7.45 mil EUR. Dividing these 2 quantities gives us the above AELIS.PA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 4.1x - 6.3x | 5.2x |
| Forward P/E multiples | 4.1x - 6.3x | 5.2x |
| Fair Price | 0.17 - (1.07) | (0.45) |
| Upside | -93.5% - -141.6% | -117.5% |
| Date | EV/EBITDA |
| 2024-12-10 | -0.38 |
| 2024-12-09 | -0.31 |
| 2024-12-06 | -0.60 |
| 2024-12-05 | -0.53 |
| 2024-12-04 | -0.60 |
| 2024-12-03 | -0.53 |
| 2024-12-02 | -0.56 |
| 2024-11-29 | -0.60 |
| 2024-11-28 | -0.60 |
| 2024-11-27 | -0.97 |
| 2024-11-26 | -0.90 |
| 2024-11-25 | -0.90 |
| 2024-11-22 | -0.93 |
| 2024-11-21 | -0.82 |
| 2024-11-20 | -1.08 |
| 2024-11-19 | -0.79 |
| 2024-11-18 | -1.04 |
| 2024-11-15 | -1.15 |
| 2024-11-14 | -1.15 |
| 2024-11-13 | -1.12 |
| 2024-11-12 | -1.12 |
| 2024-11-11 | -1.12 |
| 2024-11-08 | -1.26 |
| 2024-11-07 | -1.30 |
| 2024-11-06 | -1.74 |
| 2024-11-05 | -1.89 |
| 2024-11-04 | -2.04 |
| 2024-11-01 | -2.04 |
| 2024-10-31 | -2.04 |
| 2024-10-30 | -2.04 |
| 2024-10-29 | -1.96 |
| 2024-10-28 | -2.26 |
| 2024-10-25 | -2.26 |
| 2024-10-24 | -2.18 |
| 2024-10-23 | -2.11 |
| 2024-10-22 | -2.11 |
| 2024-10-21 | -2.48 |
| 2024-10-18 | -2.26 |
| 2024-10-17 | -2.88 |
| 2024-10-16 | -2.92 |
| 2024-10-15 | -2.92 |
| 2024-10-14 | -2.81 |
| 2024-10-11 | -2.81 |
| 2024-10-10 | -2.81 |
| 2024-10-09 | -2.77 |
| 2024-10-08 | -3.14 |
| 2024-10-07 | -3.21 |
| 2024-10-04 | -3.21 |
| 2024-10-03 | -3.25 |
| 2024-10-02 | -3.32 |